Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.75 +0.02 (+0.23%)
As of: Aug 21, 2026 · 2:31 PM EDT

Drugs Made In America Acquisition (DMAA) Selling, General & Administrative (2025)

Drugs Made In America Acquisition (DMAA) Selling, General & Administrative (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 124,777.00
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 194,528.00
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 112,227.00
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 144,182.00
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 1.47 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 115,742.00
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 96,300.00
8 Gores Holdings X 385.06 Mn 384.87 Mn - -
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 390,784.00
10 Drugs Made In America Acquisition 215.82 Mn 215.82 Mn - 136,934.00

Historic Data

Download Data
DateValue
Dec 31, 2025 2.09 Mn
Sep 30, 2025 263,703.00
Jun 30, 2025 131,919.00
Mar 31, 2025 330,925.00